Abstract:-Purpose. The early prediction of pharmacokinetic behavior is of paramount importance for saving time and resources and for increasing the success of new drug candidates. The steady-state volume of distribution (VD ss ) is one of the key pharmacokinetic parameters required for the design of a suitable dosage regimen. The aim of the study is to propose a quantitative structure -pharmacokinetics relationships (QSPkR) for VD ss of basic drugs. Methods: The data set consists of 216 basic drugs, divided to a modeli… Show more
“…QSPkRs allow prediction of PK properties at early stages of drug discovery, even on virtual compounds, thus reducing time and expense and preventing costly late-stage failures. We have previously reported QSPkR models for V d (11), pf u (12), CL (13) and t 1/2 (14) of acidic drugs, as well as for V d of basic drugs (15).…”
Purpose. Binding of drugs to plasma proteins is a common physiological occurrence which may have a profound effect on both pharmacokinetics and pharmacodynamics. The early prediction of plasma protein binding (PPB) of new drug candidates is an important step in drug development process. The present study is focused on the development of quantitative structure -pharmacokinetics relationship (QSPkR) for the negative logarithm of the free fraction of the drug in plasma (pf u ) of basic drugs. Methods. A dataset includes 220 basic drugs, which chemical structures are encoded by 176 descriptors. Genetic algorithm, stepwise regression and multiple linear regression are used for variable selection and model development. Predictive ability of the model is assessed by internal and external validation. Results. A simple, significant, interpretable and predictive QSPkR model is constructed for pf u of basic drugs. It is able to predict 59% of the drugs from an external validation set within the 2-fold error of the experimental values with squared correlation coefficient of prediction 0.532, geometric mean fold error (GMFE) 1.94 and mean absolute error (MAE) 0.17. Conclusions. PPB of basic drugs is favored by the lipophilicity, the presence of aromatic C-atoms (either non-substituted, or involved in bridged aromatic systems) and molecular volume. The fraction ionized as a base f B and the presence of quaternary Catoms contribute negatively to PPB. A short checklist of criteria for high PPB is defined, and an empirical rule for distinguishing between low, high and very high plasma protein binders is proposed based. This rule allows correct classification of 69% of the very high binders, 71% of the high binders and 91% of the low binders in plasma.
“…QSPkRs allow prediction of PK properties at early stages of drug discovery, even on virtual compounds, thus reducing time and expense and preventing costly late-stage failures. We have previously reported QSPkR models for V d (11), pf u (12), CL (13) and t 1/2 (14) of acidic drugs, as well as for V d of basic drugs (15).…”
Purpose. Binding of drugs to plasma proteins is a common physiological occurrence which may have a profound effect on both pharmacokinetics and pharmacodynamics. The early prediction of plasma protein binding (PPB) of new drug candidates is an important step in drug development process. The present study is focused on the development of quantitative structure -pharmacokinetics relationship (QSPkR) for the negative logarithm of the free fraction of the drug in plasma (pf u ) of basic drugs. Methods. A dataset includes 220 basic drugs, which chemical structures are encoded by 176 descriptors. Genetic algorithm, stepwise regression and multiple linear regression are used for variable selection and model development. Predictive ability of the model is assessed by internal and external validation. Results. A simple, significant, interpretable and predictive QSPkR model is constructed for pf u of basic drugs. It is able to predict 59% of the drugs from an external validation set within the 2-fold error of the experimental values with squared correlation coefficient of prediction 0.532, geometric mean fold error (GMFE) 1.94 and mean absolute error (MAE) 0.17. Conclusions. PPB of basic drugs is favored by the lipophilicity, the presence of aromatic C-atoms (either non-substituted, or involved in bridged aromatic systems) and molecular volume. The fraction ionized as a base f B and the presence of quaternary Catoms contribute negatively to PPB. A short checklist of criteria for high PPB is defined, and an empirical rule for distinguishing between low, high and very high plasma protein binders is proposed based. This rule allows correct classification of 69% of the very high binders, 71% of the high binders and 91% of the low binders in plasma.
“…The key PK parameters were predicted by quantitative structure–activity relationships (QSPkRs) models, derived previously 43–46 . Briefly, the PK parameters of 145 neutral and/or 262 basic drugs 47 were used to derive QSPkR models by multiple linear regression (MLR) with MDL QSAR v. 2.2 (MDL Information Systems Inc., San Leandro, CA).…”
The inhibition of the enzyme acetylcholinesterase (AChE) increases the levels of the neurotransmitter acetylcholine and symptomatically improves the affected cognitive function. In the present study, we searched for novel AChE inhibitors by docking-based virtual screening of the standard lead-like set of ZINC database containing more than 6 million small molecules using GOLD software. The top 10 best-scored hits were tested in vitro for AChE affinity, neurotoxicity, GIT and BBB permeability. The main pharmacokinetic parameters like volume of distribution, free fraction in plasma, total clearance, and half-life were predicted by previously derived models. Nine of the compounds bind to the enzyme with affinities from 0.517 to 0.735 µM, eight of them are non-toxic. All hits permeate GIT and BBB and bind extensively to plasma proteins. Most of them are low-clearance compounds. In total, seven of the 10 hits are promising for further lead optimisation. These are structures with ZINC IDs: 00220177, 44455618, 66142300, 71804814, 72065926, 96007907, and 97159977.
“…Certain criteria have been defined to discriminate between drugs with high and low VD ss . LogP has been shown to be a significant determinant of VD ss , which along with the presence of Cl atoms and molecule compactness, have a positive contribution on this descriptor, while polarity and strong electrophiles have a negative contribution on VD ss [48]. High VD ss values (> 42 L), representative of more lipophilic drugs, indicate a high likeliness of drug distribution throughout body tissues, whereas low VD ss values (< 3 L) associate with a predominant location in the systemic circulation [49].…”
Section: Interpretation Of Steroids Permeability Through Plsmentioning
One of the most challenging goals in modern pharmaceutical research is to develop models that can predict drugs’ behavior, particularly permeability in human tissues. Since the permeability is closely related to the molecular properties, numerous characteristics are necessary in order to develop a reliable predictive tool. The present study attempts to decode the permeability by correlating the apparent permeability coefficient (Papp) of 33 steroids with their properties (physicochemical and structural). The Papp of the molecules was determined by in vitro experiments and the results were plotted as Y variable on a Partial Least Squares (PLS) model, while 37 pharmacokinetic and structural properties were used as X descriptors. The developed model was subjected to internal validation and it tends to be robust with good predictive potential (R2Y = 0.902, RMSEE = 0.00265379, Q2Y = 0.722, RMSEP = 0.0077). Based on the results specific properties (logS, logP, logD, PSA and VDss) were proved to be more important than others in terms of drugs Papp. The models can be utilized to predict the permeability of a new candidate drug avoiding needless animal experiments, as well as time and material consuming experiments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.